Respiratory Care Received by Individuals With Duchenne Muscular Dystrophy From 2000 to 2011

References

1. 1.↵
   1. Romitti PA,
   2. Zhu Y,
   3. Puzhankara S,
   4. James KA,
   5. Nabukera SK,
   6. Zamba GKD,
   7. et al

   . Prevalence of Duchenne and Becker muscular dystrophies in the United States. Pediatrics 2015;135(3):513–521.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Bach JR,
   2. Alba AS

   . Management of chronic alveolar hypoventilation by nasal ventilation. Chest 1990;97(1):52–57.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.
   1. Gozal D

   . Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy. Pediatr Pulmonol 2000;29(2):141–150.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Finder JD,
   2. Birnkrant D,
   3. Carl J,
   4. Farber HJ,
   5. Gozal D,
   6. Iannaccone ST,
   7. et al

   . Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 2004;170(4):456–465.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Humbertclaude V,
   2. Hamroun D,
   3. Bezzou K,
   4. Bérard C,
   5. Boespflug-Tanguy O,
   6. Bommelaer C,
   7. et al

   . Motor and respiratory heterogeneity in Duchenne patients: implication for clinical trials. Eur J Paediatr Neurol 2012;16(2):149–160.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Benditt JO,
   2. Boitano L

   . Respiratory support of individuals with Duchenne muscular dystrophy: toward a standard of care. Phys Med Rehabil Clin N Am 2005;16(4):1125–1139, xii.

   OpenUrlPubMed
7. 7.↵
   1. Boitano LJ

   . Management of airway clearance in neuromuscular disease. Respir Care 2006;51(8):913–922; discussion 922-924.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Eagle M,
   2. Bourke J,
   3. Bullock R,
   4. Gibson M,
   5. Mehta J,
   6. Giddings D,
   7. et al

   . Managing Duchenne muscular dystrophy: the additive effect of spinal surgery and home nocturnal ventilation in improving survival. Neuromuscul Disord 2007;17(6):470–475.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Ishikawa Y,
   2. Miura T,
   3. Ishikawa Y,
   4. Aoyagi T,
   5. Ogata H,
   6. Hamada S,
   7. Minami R

   . Duchenne muscular dystrophy: survival by cardio-respiratory interventions. Neuromuscul Disord 2011;21(1):47–51.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Bach JR,
    2. Ishikawa Y,
    3. Kim H

    . Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest 1997;112(4):1024–1028.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Gomez-Merino E,
    2. Bach JR

    . Duchenne muscular dystrophy: prolongation of life by noninvasive ventilation and mechanically assisted coughing. Am J Phys Med Rehabil 2002;81(6):411–415.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.
    1. Jeppesen J,
    2. Green A,
    3. Steffensen BF,
    4. Rahbek J

    . The Duchenne muscular dystrophy population in Denmark, 1977-2001: prevalence, incidence and survival in relation to the introduction of ventilator use. Neuromuscul Disord 2003;13(10):804–812.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.
    1. Simonds AK

    . Recent advances in respiratory care for neuromuscular disease. Chest 2006;130(6):1879–1886.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.
    1. Toussaint M,
    2. Chatwin M,
    3. Soudon P

    . Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency: clinical implications of 20 years published experience. Chron Respir Dis 2007;4(3):167–177.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Toussaint M,
    2. Soudon P,
    3. Kinnear W

    . Effect of non-invasive ventilation on respiratory muscle loading and endurance in patients with Duchenne muscular dystrophy. Thorax 2008;63(5):430–434.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Birnkrant DJ,
    2. Bushby KM,
    3. Amin RS,
    4. Bach JR,
    5. Benditt JO,
    6. Eagle M,
    7. et al

    . The respiratory management of patients with Duchenne muscular dystrophy: a DMD Care Considerations Working Group specialty article. Pediatr Pulmonol 2010;45(8):739–748.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Bushby K,
    2. Finkel R,
    3. Birnkrant DJ,
    4. Case LE,
    5. Clemens PR,
    6. Cripe L,
    7. et al

    . Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010;9(1):77–93.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Bushby K,
    2. Finkel R,
    3. Birnkrant DJ,
    4. Case LE,
    5. Clemens PR,
    6. Cripe L,
    7. et al

    . Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010;9(2):177–189.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Miller LA,
    2. Romitti PA,
    3. Cunniff C,
    4. Druschel C,
    5. Mathews KD,
    6. Meaney FJ,
    7. et al

    . The Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology. Birth Defects Res A Clin Mol Teratol 2006;76(11):793–797.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Mathews KD,
    2. Cunniff C,
    3. Kantamneni JR,
    4. Ciafaloni E,
    5. Miller T,
    6. Matthews D,
    7. et al

    . Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): case definition in surveillance for childhood-onset Duchenne/Becker muscular dystrophy. J Child Neurol 2010;25(9):1098–1102.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Imbornoni L,
    2. Price ET,
    3. Andrews J,
    4. Meaney FJ,
    5. Ciafaloni E,
    6. Cunniff C

    . Diagnostic and clinical characteristics of early-manifesting females with Duchenne or Becker muscular dystrophy. Am J Med Genet A 2014;164A(11):2769–2774.

    OpenUrl
22. 22.↵
    1. Kim S,
    2. Campbell KA,
    3. Fox DJ,
    4. Matthews DJ,
    5. Valdez R

    . Corticosteroid treatments in males with Duchenne muscular dystrophy: treatment duration and time to loss of ambulation. J Child Neurol 2015;30(10):1275–1280.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Fox DJ,
    2. Kumar A,
    3. West NA,
    4. DiRienzo AG,
    5. James KA,
    6. Oleszek J

    , Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). Trends with corticosteroid use in males with Duchenne muscular dystrophy born 1982-2001. J Child Neurol 2015;30(1):21–26.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Eagle M,
    2. Baudouin SV,
    3. Chandler C,
    4. Giddings DR,
    5. Bullock R,
    6. Bushby K

    . Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 2002;12(10):926–929.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. Katz SL,
    2. McKim D,
    3. Hoey L,
    4. Barrowman N,
    5. Kherani T,
    6. Kovesi T,
    7. et al

    . Respiratory management strategies for Duchenne muscular dystrophy: practice variation amongst Canadian subspecialists. Pediatr Pulmonol 2013;48(1):59–66.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Rodger S,
    2. Woods KL,
    3. Bladen CL,
    4. Stringer A,
    5. Vry J,
    6. Gramsch K,
    7. et al

    . Adult care for Duchenne muscular dystrophy in the UK. J Neurol 2015;262(3):629–641.

    OpenUrlPubMed
27. 27.↵
    1. Francke AL,
    2. Smit MC,
    3. de Veer AJ,
    4. Mistiaen P

    . Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak 2008;8:38–49.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Cabana MD,
    2. Rand CS,
    3. Powe NR,
    4. Wu AW,
    5. Wilson MH,
    6. Abboud PA,
    7. Rubin HR

    . Why don't physicians follow clinical practice guidelines: a framework for improvement. JAMA 1999;282(15):1458–1465.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Bach JR,
    2. Chaudhry SS

    . Standards of care in MDA clinics: Muscular Dystrophy Association. Am J Phys Med Rehabil 2000;79(2):193–196.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    1. Pandya SK,
    2. Campbell KA,
    3. Andrews JG,
    4. Meaney FJ,
    5. Ciafaloni E

    . Health services received by individuals with Duchenne/Becker muscular dystrophy. Muscle Nerve 2016;53(2):191–197

    OpenUrlPubMed
31. 31.↵
    1. Finder JD

    . A 2009 perspective on the 2004 American Thoracic Society Statement, “respiratory care of the patient with Duchenne muscular dystrophy.” Pediatrics 2009;123(Suppl 4):S239–S241.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Bach JR,
    2. Gonçalves MR,
    3. Hamdani I,
    4. Winck JC

    . Extubation of patients with neuromuscular weakness: a new management paradigm. Chest 2010;137(5):1033–1039.

    OpenUrlCrossRefPubMedWeb of Science